Rafferty Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Sell |
|
|||||
|
2025
Q1 | $3.22M | Sell |
|
|||||
|
2024
Q4 | $4.26M | Buy |
|
|||||
|
2024
Q3 | $5.47M | Sell |
|
|||||
|
2024
Q2 | $5.19M | Sell |
|
|||||
|
2024
Q1 | $8.47M | Sell |
|
|||||
|
2023
Q4 | $10.6M | Buy |
|
|||||
|
2023
Q3 | $6.53M | Buy |
|
|||||
|
2023
Q2 | $7.46M | Sell |
|
|||||
|
2023
Q1 | $7.04M | Sell |
|
|||||
|
2022
Q4 | $9.19M | Buy |
|
|||||
|
2022
Q3 | $5.83M | Buy |
|
|||||
|
2022
Q2 | $4.57M | Sell |
|
|||||
|
2022
Q1 | $5.94M | Buy |
|
|||||
|
2021
Q4 | $5.69M | Buy |
|
|||||
|
2021
Q3 | $2.76M | Buy |
|
|||||
|
2021
Q2 | $2.44M | Sell |
|
|||||
|
2021
Q1 | $2.99M | Buy |
|
|||||
|
2020
Q4 | $891K | Sell |
|
|||||
|
2020
Q3 | $2.21M | Buy |
|
|||||
|
2020
Q2 | $1.1M | Buy |
|
|||||
|
2020
Q1 | $298K | Sell |
|
|||||
|
2019
Q4 | $2.43M | Sell |
|
|||||
|
2019
Q3 | $4.23M | Buy |
|
|||||
|
2019
Q2 | $5.49M | Buy |
|
|||||
|
2019
Q1 | $4.51M | Buy |
|